Table 1. Demographic and clinical characteristics of PD and control group for the five-day practice sessions.
PD (n = 19) | CG (n = 19) | |||||
Variable | M | SD | Range | M | SD | Range |
Age | 63.9 | 8.8 | 45–77 | 64.8 | 10.1 | 44–80 |
Duration of PD (years) | 6.8 | 5.7 | 1–20 | |||
UPDRS motor score | 26 | 9 | 11–41 | |||
H&Y | 1.5–3 | |||||
MMSE | 27.6 | 2.3 | 22–30 | 28.6 | 1.3 | 26–30 |
Medication (mg): Levodopa (n = 19) | 459.5 | 192 | 187.5–900 | |||
Carbidopa (n = 19) | 112 | 48 | 47–187.5 | |||
Entacapon (n = 8) | 771.4 | 335.2 | 200–1200 |
UPDRS = Unified Parkinson's disease Rating Scale.
H&Y = Hoehn and Yahr rating scale.
MMSE = Mini Mental State Examination.